Verification evidence is still being completed.
PDF / print export
PharmIdea
Olaine, Latvia
- Verified lead
- Vitalijs Skrivelis
- Lead status
- STATUS: VERIFIED MARCH 2026
- Leadership verification
- Chief Executive Officer and Member of the Board
- 2026 technical specialization
- Sterile Products
- Review cycle
- May 2026
- Full address
- Rūpnīcu iela 4, Olaine, LV-2114, Latvia
- Site coordinates
- Verification evidence is still being completed.
- Editorial review
- Memel Biotech editorial review
- Official leadership source
- Official PharmIdea management page confirming Vitalijs Skrivelis as CEO and board member.
- Editorial note
- Grade A/B sterile manufacturing with automated fill-finish, lyophilization, and up to 600 L bioprocess support for regional supply programs.
Sterile Products
GMP Certified, EU-GMP
Grade A/B sterile manufacturing with automated fill-finish, lyophilization, and up to 600 L bioprocess support for regional supply programs.
Review coverage
Leadership
Facility
Certifications
Capabilities
Partners
Sources
Quality
Editorial verificationMemel Biotech directory review sign-off
Report generated02 Jun 2026, 01:40
Grade A/B sterile manufacturing with automated fill-finish, lyophilization, and up to 600 L bioprocess support for regional supply programs.
- Lead
- Vitalijs Skrivelis (verified ↗)
- Address
- Rūpnīcu iela 4, Olaine, LV-2114, Latvia (source ↗)
- Compliance
- GMP Certified · EU-GMP
- Last reviewed
- 14 Mar 2026 (3mo ago)
- Scale
- Commercial Pilot
- Capabilities
- Aseptic Filling · Lyophilization · Cytotoxic Drug Handling
- Founded
- 2007
- Headcount
- 51-200
- Company page (open ↗)
Clinical profileSTATUS: VERIFIED MARCH 2026
Vitalijs Skrivelis
Chief Executive Officer and Member of the Board
Full addressRūpnīcu iela 4, Olaine, LV-2114, Latvia
Site coordinatesVerification evidence is still being completed.
Review cycleMay 2026
Physical site source
Official PharmIdea company and careers pages identifying the production site at Rūpnīcu iela 4, Olaine.
Open sourceCommercial Pilot
Olaine, Latvia. Sterile Products. Review completed on 14 Mar 2026.
SAM (Latvia)
GMP Certified, EU-GMP
Sterile Products
Grade A/B sterile manufacturing with automated fill-finish, lyophilization, and up to 600 L bioprocess support for regional supply programs.
Related companies
Editorial note
PharmIdea is published as an Olaine sterile-manufacturing site with a current executive record, a visible factory address, and live EU-GMP-oriented service positioning.
FULL TRUST REVIEW COMPLETE
Shown only when all seven trust checks are fully mapped in the directory.
Current review cycleMarch 2026
Capabilities
Core capabilities
Primary declared technical activities and areas of operating focus.
Aseptic Filling
Lyophilization
Cytotoxic Drug Handling
Verification source dossier
Verification source dossier
Official source set used to support leadership, physical-site, certification, and watch-note evidence.
Infrastructure
Declared infrastructure
Automated Fill-Finish Lines
Lyophilizers
Regulatory posture
Quality system coverage
GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.
- GMP
- VERIFIED ACTIVE 2026
- GLP
- REVIEW IN PROGRESS 2026
- ISO-13485
- REVIEW IN PROGRESS 2026
- FDA-Inspected
- REVIEW IN PROGRESS 2026
Verification history
Verification history
14 Mar 2026: Executive identity confirmed via official management disclosure.
14 Mar 2026: Full trust review completed.
FAQ
Frequently asked questions
- Where is PharmIdea located?
- PharmIdea operates from Rūpnīcu iela 4, Olaine, LV-2114, Latvia, Olaine, Latvia.
- Who runs PharmIdea?
- PharmIdea is led by Vitalijs Skrivelis, Chief Executive Officer and Member of the Board. Verified 14 Mar 2026.
- What certifications does PharmIdea hold?
- PharmIdea is documented under GMP Certified, EU-GMP.
- What does PharmIdea do?
- Grade A/B sterile manufacturing with automated fill-finish, lyophilization, and up to 600 L bioprocess support for regional supply programs. Core capabilities: Aseptic Filling, Lyophilization, Cytotoxic Drug Handling.
Editorial context
Related technical briefs
Briefs that name Olaine as a covered market or city.